Home › Colorectal Cancer › Arizona › Scottsdale
Colorectal Cancer clinical trials in Scottsdale, AZ
16 studies for Colorectal Cancer are looking for participants at sites in and around Scottsdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
RecruitingPhase 1
- Honor Health Research Institute, Scottsdale
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Mayo Clinic, Scottsdale
- Ironwood Cancer & Research Centers, Scottsdale
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- HonorHealth, Scottsdale
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
RecruitingPhase 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RecruitingPhase 2
- Research Site, Scottsdale
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
RecruitingObservational study
- Mayo Clinic in Arizona, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Honor Health, Scottsdale
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Mayo Clinic (Arizona), Scottsdale
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
RecruitingPhase 3
- Mayo Clinic, Scottsdale
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecruitingPhase 1
- Mayo Clinic, Scottsdale
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
RecruitingHealthy volunteers welcome
- Mayo Clinic in Arizona, Scottsdale
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
RecruitingPhase 1/2
- Clinical Trials Nurse Navigator, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RecruitingPhase 4
- Scottsdale Medical Imaging, LLC, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RecruitingPhase 1/2
- Mayo Clinic in Arizona, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RecruitingPhase 1
- HonorHealth Research Institute, Scottsdale
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Scottsdale
- Breast Cancer18 studies
- Cancer (all types)18 studies
- Metastatic Cancer17 studies
- Prostate Cancer17 studies
- Non-Small Cell Lung Cancer15 studies
- Pancreatic Cancer13 studies
- Melanoma10 studies
- Ulcerative Colitis8 studies
- Lung Cancer8 studies
- Liver Cancer (Hepatocellular Carcinoma)7 studies
- Alzheimer's Disease7 studies
- Triple-Negative Breast Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.